Role of Insulin and Adenosine in the Human Placenta Microvascular and Macrovascular Endothelial Cell Dysfunction in Gestational Diabetes Mellitus

Microcirculation

Volumn 21, Issue 1, 2014, Pages 26-37

  Guzmán Gutiérrez, Enrique ^a   Arroyo, Pablo ^a   Salsoso, Rocío ^a   Fuenzalida, Bárbara ^a,b   Sáez, Tamara ^a   Leiva, Andrea ^a   Pardo, Fabián ^a   Sobrevia, Luis ^a,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE ANTOFAGASTA   (Chile)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Arginine membrane transport; Endothelial dysfunction; Nitric oxide; Pregnancy

Indexed keywords

ADENOSINE; ARGININE; INSULIN; NITRIC OXIDE;

ARTICLE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HORMONE DETERMINATION; HUMAN; MACROVASCULAR ENDOTHELIAL CELL; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR DYNAMICS; NONHUMAN; PLACENTA CIRCULATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REGULATORY MECHANISM;

ARGININE MEMBRANE TRANSPORT; ENDOTHELIAL DYSFUNCTION; NITRIC OXIDE; PREGNANCY;

ADENOSINE; ARGININE; DIABETES, GESTATIONAL; ENDOTHELIAL CELLS; FEMALE; HUMANS; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PLACENTA; PREGNANCY;

EID: 84888354727     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12077     Document Type: Article

References (102)

1. Aceti A, Santhakumaran S, Logan KM, Philipps LH, Prior E, Gale C, Hyde MJ, Modi N. The diabetic pregnancy and offspring blood pressure in childhood: a systematic review and meta-analysis. Diabetologia 55: 3114-3127, 2012.
2. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 27: S88-S90, 2004.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35: S64-S71, 2012.
4. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447: 735-743, 2004.
5. Barrett HL, Morris J, McElduff A. Watchful waiting: a management protocol for maternal glycaemia in the peripartum period. Aust N Z J Obstet Gynaecol 49: 162-167, 2009.
6. Becker BF, Kupatt C, Massoudy P, Zahler S. Reactive oxygen species and nitric oxide in myocardial ischemia and reperfusion. Z Kardiol 89(Suppl. 9:IX): 88-91, 2000.
7. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30: 586-623, 2009.
8. Bergandi L, Silvagno F, Russo I, Riganti C, Anfossi G, Aldieri E, Ghigo D, Trovati M, Bosia A. Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 2215-2221, 2003.
9. Berne RM, Knabb RM, Ely SW, Rubio R. Adenosine in the local regulation of blood flow: a brief overview. Fed Proc 42: 3136-3142, 1983.
10. Biri A, Onan A, Devrim E, Babacan F, Kavutcu M, Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 27: 327-332, 2006.
11. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115: e290-e296, 2005.
12. Brown MA, North L, Hargood J. Uteroplacental Doppler ultrasound in routine antenatal care. Aust N Z J Obstet Gynaecol 30: 303-307, 1990.
13. Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 8: 639-649, 2012.
14. Burnstock G. Vessel tone and remodeling. Nat Med 12: 16-17, 2006.
15. Burnstock G, Fredholm BB, North RA, Verkhratsky A. The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) 199: 93-147, 2010.
16. Burnstock G, Novak I. Purinergic signalling and diabetes. Purinergic Signal, 2013. doi:10.1007/s11302-013-9359-2.
17. Cetin I, de Santis MS, Taricco E, Radaelli T, Teng C, Ronzoni S, Spada E, Milani S, Pardi G. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol 192: 610-617, 2005.
18. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 30: 2070-2076, 2007.
19. Cifuentes F, Palacios J, Vega JL, Casanello P, Sobrevia L. Vasocontriction induced by serotonin is reduced by adenosine in human umbilical vein from gestational diabetes. Placenta 31: A35, 2010. (Abstract)
20. Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J, Schmidt L, Damm P. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab 94: 2464-2470, 2009.
21. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol 213: 67-77, 2006.
22. Colomiere M, Permezel M, Riley C, Desoye G, Lappas M. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 160: 567-578, 2009.
23. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30: S120-S126, 2007.
24. Devés R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78: 487-545, 1998.
25. Durnwald C, Landon M. Fetal links to chronic disease: the role of gestational diabetes mellitus. Am J Perinatol 30: 343-346, 2013.
26. Dye JF, Vause S, Johnston T, Clark P, Firth JA, D'Souza SW, Sibley CP, Glazier JD. Characterization of cationic amino acid transporters and expression of endothelial nitric oxide synthase in human placental microvascular endothelial cells. FASEB J 18: 125-127, 2004.
27. Ebina Y, Edery M, Ellis L, Standring D, Beaudoin J, Roth RA, Rutter WJ. Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. Proc Natl Acad Sci USA 82: 8014-8018, 1985.
28. Ellerbe CN, Gebregziabher M, Korte JE, Mauldin J, Hunt KJ. Quantifying the impact of gestational diabetes mellitus, maternal weight and race on birthweight via quantile regression. PLoS ONE 8: e65017, 2013.
29. Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology 111: 904-915, 2009.
30. 2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta 29: 816-825, 2008.
31. Farías M, Puebla C, Westermeier F, Jo MJ, Pastor-Anglada M, Casanello P, Sobrevia L. Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPα in human umbilical vein endothelial cells from gestational diabetes. Cardiovasc Res 86: 45-54, 2010.
32. 2 in human placental vessels from gestational diabetic pregnancies. Am J Physiol 278: H706-H713, 2000.
33. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19: 3278-3288, 1999.
34. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63: 1-34, 2011.
35. Genua M, Pandini G, Sisci D, Castoria G, Maggiolini M, Vigneri R, Belfiore A. Role of cyclic AMP response element-binding protein in insulin-like growth factor-I receptor up-regulation by sex steroids in prostate cancer cells. Cancer Res 69: 7270-7277, 2009.
36. Giudice J, Barcos LS, Guaimas FF, Penas-Steinhardt A, Giordano L, Jares-Erijman EA, Coluccio Leskow F. Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B. Cell Commun Signal 11: 18, 2013. doi:10.1186/1478-811X-11-18.
37. González M, Gallardo V, Rodríguez N, Salomón C, Westermeier F, Guzmán-Gutiérrez E, Abarzúa F, Leiva A, Casanello P, Sobrevia L. Insulin-stimulated L-arginine transport requires SLC7A1 gene expression and is associated with human umbilical vein relaxation. J Cell Physiol 226: 2916-2924, 2011.
38. González M, Muñoz E, Puebla C, Guzmán-Gutiérrez E, Cifuentes F, Nien JK, Abarzúa F, Leiva A, Casanello P, Sobrevia L. Maternal and fetal metabolic dysfunction in pregnancy diseases associated with vascular oxidative and nitrative stress. In: The Molecular Basis for Origin of Fetal Congenital Abnormalities and Maternal Health: An Overview of Association with Oxidative Stress, edited by Matata BM, Elahi M. USA: Bentham, 2011, p. 98-115.
39. Guzmán-Gutiérrez E, Arroyo P, Pardo F, Leiva A, Sobrevia L. The adenosine-insulin signalling axis in the fetoplacental endothelial dysfunction in gestational diabetes. In: Gestational Diabetes - Causes, Diagnosis and Treatment, edited by Sobrevia L. New York: In Tech, 2013, p. 49-77.
40. 2A adenosine receptors activation in human umbilical vein endothelium. PLoS ONE 7: e41705, 2012.
41. Hammermann R, Brunn G, Racké K. Analysis of the genomic organization of the human cationic amino acid transporters CAT-1, CAT-2 and CAT-4. Amino Acids 21: 211-219, 2001.
42. Hiden U, Glitzner E, Hartmann M, Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J Anat 215: 60-68, 2009.
43. Irie K, Tsukahara F, Fujii E, Uchida Y, Yoshioka T, He WR, Shitashige M, Murota S, Muraki T. Cationic amino acid transporter-2 mRNA induction by tumor necrosis factor-alpha in vascular endothelial cells. Eur J Pharmacol 339: 289-293, 1997.
44. Jarvis SM, Young JD. Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites. Biochem J 190: 377-383, 1980.
45. Jo M, Krause B, Casanello P, Sobrevia L. Differential reactivity to insulin in human umbilical and chorionic vessels from normal and gestational diabetic pregnancies. DOHaD 1: S307, 2009. (Abstract)
46. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006.
47. Klinger M, Freissmuth M, Nanoff C. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal 14: 99-108, 2002.
48. Leach L. Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation 18: 263-269, 2011.
49. Leiva A, de Medina CD, Guzmán-Gutiérrez E, Pardo F, Sobrevia L. Maternal hypercholesterolemia in gestational diabetes and the association with placental endothelial dysfunction. In: Gestational Diabetes - Causes, Diagnosis and Treatment, edited by Sobrevia L. New York: In Tech, 2013, p. 103-133.
50. Leiva A, Pardo F, Ramírez MA, Farías M, Casanello P, Sobrevia L. Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy. Exp Diabetes Res 2011: 349286, 2011.
51. Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LF, Breier BH, Johnstone FD. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol 66: 322-328, 2007.
52. Maguire MH, Szabó I, Valkó IE, Finley BE, Bennett TL. Simultaneous measurement of adenosine and hypoxanthine in human umbilical cord plasma using reversed-phase high-performance liquid chromatography with photodiode-array detection and on-line validation of peak purity. J Chromatogr B Biomed Sci Appl 707: 33-41, 1998.
53. Mann GE, Yudilevich DL, Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83: 183-252, 2003.
54. Marzioni D, Tamagnone L, Capparuccia L, Marchini C, Amici A, Todros T, Bischof P, Neidhart S, Grenningloh G, Castellucci M. Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A. Dev Dyn 231: 839-848, 2004.
55. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30: S251-S260, 2007.
56. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on gestational diabetes mellitus. The Organizing Committee. Diabetes Care 21: B161-B167, 1998.
57. Moller DE, Yokota A, Caro JF, Flier JS. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3: 1263-1269, 1989.
58. Moore TR. Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. Am J Obstet Gynecol 202: 643-649, 2010.
59. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 9: 2409-24013, 1990.
60. Mundell S, Kelly E. Adenosine receptor desensitization and trafficking. Biochim Biophys Acta 1808: 1319-1328, 2011.
61. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 28: 463-491, 2007.
62. Nitert MD, Chisalita SI, Olsson K, Bornfeldt KE, Arnqvist HJ. IGF-I/insulin hybrid receptors in human endothelial cells. Mol Cell Endocrinol 229: 31-37, 2005.
63. Norgren S, Li LS, Luthman H. Regulation of human insulin receptor RNA splicing in HepG2 cells: effects of glucocorticoid and low glucose concentration. Biochem Biophys Res Commun 199: 277-284, 1994.
64. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 70: 761-845, 1990.
65. 2B adenosine receptors to reverse gestational diabetes reduced L-arginine transport in human placental microvascular endothelial cells. J Mol Cell Card 53: A6, 2012. (Abstract)
66. Pandolfi A, Di Pietro N. High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia? Cardiovasc Res 86: 9-11, 2010.
67. Phillips DI. Birth weight and the future development of diabetes. A review of the evidence. Diabetes Care 21: 150-155, 1998.
68. Pietryga M, Brazert J, Wender-Ozegowska E, Dubiel M, Gudmundsson S. Placental Doppler velocimetry in gestational diabetes mellitus. J Perinat Med 34: 108-110, 2006.
69. Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitichel M, Rice GE. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS ONE 8: e68451, 2013.
70. Salomon C, Sobrevia L, Ashman K, Illanes S, Mitchell M, Rice G. The role of placental exosomes in gestational diabetes mellitus. In: Gestational Diabetes - Causes, Diagnosis and Treatment, edited by Sobrevia L. New York: In Tech, 2013, p. 29-49.
71. Salomon C, Westermeier F, Puebla C, Arroyo P, Guzmán-Gutiérrez E, Pardo F, Leiva A, Casanello P, Sobrevia L. Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin. PLoS ONE 7: e40578, 2012.
72. San Martín R, Sobrevia L. Gestational diabetes and the adenosine/l-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 27: 1-10, 2006.
73. Savkur R, Philips V, Cooper H. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29: 40-47, 2001.
74. 2B receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp Cell Res 290: 168-176, 2003.
75. Sciacca L, Cassarino MF, Genua M, Pandini G, Le Moli R, Squatrito S, Vigneri R. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia 53: 1743-1753, 2010.
76. Sciacca L, Prisco M, Wu A, Belfiore A, Vigneri R, Baserga R. Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. Endocrinology 144: 2650-2658, 2003.
77. Sen S, Talukdar I, Liu Y, Tam J, Reddy S, Webster NJ. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer. J Biol Chem 285: 25426-25437, 2010.
78. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15: 2099-2111, 2001.
79. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and l-arginine transport. J Biol Chem 271: 23928-23937, 1996.
80. Sivaraman SC, Vinnamala S, Jenkins D. Gestational diabetes and future risk of diabetes. J Clin Med Res 5: 92-96, 2013.
81. Sobrevia L, Abarzúa F, Nien JK, Salomón C, Westermeier F, Puebla C, Cifuentes F, Guzmán-Gutiérrez E, Leiva A, Casanello P. Review: differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta 32: S159-S164, 2011.
82. + and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol 489: 183-192, 1995.
83. Sobrevia L, González M. A role for insulin on l-arginine transport in fetal endothelial dysfunction in hyperglycaemia. Curr Vasc Pharmacol 7: 467-474, 2009.
84. Sobrevia L, Mann GE. Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp Physiol 82: 423-452, 1997.
85. Sobrevia B, Sobrevia L, Leiva A. Maternal supraphysiological hypercholesterolemia reduces the endothelium-dependent dilation of the human placental microvasculature. ISCOMS 20th International Students Congress of (Bio) Medical Sciences, 4 June. www.iscoms.com, 2013. (Abstract)
86. +) and nitric oxide synthesis in human fetal endothelial cells. J Physiol 499: 135-140, 1997.
87. Thorsøe KS, Schlein M, Steensgaard DB, Brandt J, Schluckebier G, Naver H. Kinetic evidence for the sequential association of insulin binding sites 1 and 2 to the insulin receptor and the influence of receptor isoform. Biochemistry 49: 6234-6246, 2010.
88. Tong BC, Barbul A. Cellular and physiological effects of arginine. Mini Rev Med Chem 4: 823-832, 2004.
89. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756-761, 1985.
90. Vásquez R, Farías M, Vega JL, Martin RS, Vecchiola A, Casanello P, Sobrevia L. D-Glucose stimulation of l-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J Cell Physiol 212: 626-632, 2007.
91. Vásquez G, Sanhueza F, Vásquez R, González M, San Martín R, Casanello P, Sobrevia L. Role of adenosine transport in gestational diabetes-induced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 560: 111-122, 2004.
92. Vega JL, Puebla C, Vásquez R, Farías M, Alarcón J, Pastor-Anglada M, Krause B, Casanello P, Sobrevia L. TGF-β1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium. Cardiovasc Res 82: 458-467, 2009.
93. Visigalli R, Barilli A, Bussolati O, Sala R, Gazzola GC, Parolari A, Tremoli E, Simon A, Closs EI, Dall'Asta V. Rapamycin stimulates arginine influx through CAT2 transporters in human endothelial cells. Biochim Biophys Acta 1768: 1479-1487, 2007.
94. von Mandach U, Lauth D, Huch R. Maternal and fetal nitric oxide production in normal and abnormal pregnancy. J Matern Fetal Neonatal Med 13: 22-27, 2003.
95. Wang Q, Huang R, Yu B, Cao F, Wang H, Zhang M, Wang X, Zhang B, Zhou H, Zhu Z. Higher fetal insulin resistance in Chinese pregnant women with gestational diabetes mellitus and correlation with maternal insulin resistance. PLoS ONE 8: e59845, 2013.
96. Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Carter SM, Craigo SD, Carr SR, D'Alton ME; FASTER Research Consortium. Obesity, obstetric complications and cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol 190: 1091-1097, 2004.
97. Westermeier F, Puebla C, Vega JL, Farías M, Escudero C, Casanello P, Sobrevia L. Equilibrative nucleoside transporters in fetal endothelial dysfunction in diabetes mellitus and hyperglycaemia. Curr Vasc Pharmacol 7: 435-449, 2009.
98. Westermeier F, Salomón C, González M, Puebla C, Guzmán-Gutiérrez E, Cifuentes F, Leiva A, Casanello P, Sobrevia L. Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes 60: 1677-1687, 2011.
99. Westgate JA, Lindsay RS, Beattie J, Pattison NS, Gamble G, Mildenhall LF, Breier BH, Johnstone FD. Hyperinsulinemia in cord blood in mothers with type 2 diabetes and gestational diabetes mellitus in New Zealand. Diabetes Care 29: 1345-1350, 2006.
100. Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 37: 1-17, 2009.
101. Youngren JF. Regulation of insulin receptor function. Cell Mol Life Sci 64: 873-891, 2007.
102. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98: 894-898, 1996.